Skip to main content
TipRanks
Go Ultimate75% OFF
Thryv Therapeutics logo

Thryv Therapeutics: Valuation, Funding & Investors

A biopharmaceutical company developing therapies for cardiovascular diseases. Its research focuses on SGK1 inhibition and treatments for heart failure and Long QT Syndrome.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$30M
Total Funding Rounds
1
Latest Funding Amount
$30M
Latest Funding Round
Series B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Nov 03, 2026Series B$30.00M―

Investors

Investor NameFunding Round
InClin, Inc.Series B

Similar Companies

A snapshot of private companies similar to Thryv Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis